Log In
BCIQ
Print this Print this
 

NeoTYPE prognostic panel for chronic lymphocytic leukemia (CLL)

  Manage Alerts
Collapse Summary General Information
Company NeoGenomics Inc.
DescriptionAssays to detect mutations in the splicing factor 3B subunit 1 (SF3B1) gene, IgVH mutation analysis, ZAP70 expression measured by flow cytometry and FISH tests targeting abnormalities of genes associated with CLL
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsDiagnose chronic lymphocytic leukemia
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today